By Ben Hirschler and Kate Kelland LONDON (Reuters) – The drugs don’t work – and neither does the market, when it comes to antibiotics. Just over a year ago, Johnson & Johnson won approval for the first drug in 40 years that provides a new way to treat TB, yet sales of Sirturo are forecast by analysts to total just $75 million this year.
Source: https://in.news.yahoo.com/fix-broken-market-antibiotics-091206048–finance.html